These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36389774)

  • 61. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.
    Khoruts A; Staley C; Sadowsky MJ
    Nat Rev Gastroenterol Hepatol; 2021 Jan; 18(1):67-80. PubMed ID: 32843743
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expert opinion on fecal microbiota transplantation for the treatment of
    Kumar V; Fischer M
    Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
    [No Abstract]   [Full Text] [Related]  

  • 63. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
    Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
    Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives.
    Raeisi H; Noori M; Azimirad M; Mohebbi SR; Asadzadeh Aghdaei H; Yadegar A; Zali MR
    Gut Pathog; 2023 May; 15(1):21. PubMed ID: 37161478
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
    Quraishi MN; Widlak M; Bhala N; Moore D; Price M; Sharma N; Iqbal TH
    Aliment Pharmacol Ther; 2017 Sep; 46(5):479-493. PubMed ID: 28707337
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
    Haber SL; Raney CRK; Larson TL; Lau JP
    Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Romanian National Guideline on Translating Fecal Microbiota Transplantation Applications related to Clostridioides difficile Infections into the Local Clinical Practice.
    Gilca-Blanariu GE; Stefanescu G; Girleanu I; Iqbal T; Segal J; Mullish B; Quraishi MN; Keller J; Molnar T; Megraud F; Dumitrascu D; Manuc M; Iancu LS; Marica C; Gheorghe C; Manzoor S; Trifan A
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):147-163. PubMed ID: 33723543
    [TBL] [Abstract][Full Text] [Related]  

  • 68.
    Cortés P; Bi Y; Stancampiano F; Valery JR; Cooper JH; Harris DM
    Rom J Intern Med; 2021 Sep; 59(3):262-269. PubMed ID: 33713592
    [No Abstract]   [Full Text] [Related]  

  • 69. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.
    Cammarota G; Ianiro G; Gasbarrini A
    J Clin Gastroenterol; 2014 Sep; 48(8):693-702. PubMed ID: 24440934
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.
    Youngster I; Sauk J; Pindar C; Wilson RG; Kaplan JL; Smith MB; Alm EJ; Gevers D; Russell GH; Hohmann EL
    Clin Infect Dis; 2014 Jun; 58(11):1515-22. PubMed ID: 24762631
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts.
    Fujimoto K; Kimura Y; Shimohigoshi M; Satoh T; Sato S; Tremmel G; Uematsu M; Kawaguchi Y; Usui Y; Nakano Y; Hayashi T; Kashima K; Yuki Y; Yamaguchi K; Furukawa Y; Kakuta M; Akiyama Y; Yamaguchi R; Crowe SE; Ernst PB; Miyano S; Kiyono H; Imoto S; Uematsu S
    Cell Host Microbe; 2020 Sep; 28(3):380-389.e9. PubMed ID: 32652061
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
    Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
    World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

  • 76. Fecal microbiota transplantation: a review on current formulations in
    Rakotonirina A; Galperine T; Allémann E
    Expert Opin Biol Ther; 2022 Jul; 22(7):929-944. PubMed ID: 35763604
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomised clinical trial: a 12-strain bacterial mixture versus faecal microbiota transplantation versus vancomycin for recurrent Clostridioides difficile infections.
    Rode AA; Chehri M; Krogsgaard LR; Heno KK; Svendsen AT; Ribberholt I; Helms M; Engberg J; Schønning K; Tvede M; Andersen CØ; Jensen US; Petersen AM; Bytzer P
    Aliment Pharmacol Ther; 2021 May; 53(9):999-1009. PubMed ID: 33694229
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
    Khanna S; Pardi D
    Am J Gastroenterol; 2020 Jul; 115(7):971-974. PubMed ID: 32618640
    [No Abstract]   [Full Text] [Related]  

  • 79. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
    Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
    BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Systematic Review of Fecal Microbiota Transplantation Versus Vancomycin for Treatment of Recurrent Clostridioides difficile Infection.
    Leung J; Pham S
    Gastroenterol Nurs; 2021 Mar-Apr 01; 44(2):106-115. PubMed ID: 33795620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.